Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,132 | 127 | 99.5% |
| Gift | $11.24 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $330.25 | 20 | $0 (2020) |
| GENZYME CORPORATION | $199.89 | 12 | $0 (2019) |
| PFIZER INC. | $164.20 | 13 | $0 (2019) |
| UCB, Inc. | $129.27 | 9 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $99.34 | 2 | $0 (2020) |
| Daiichi Sankyo Inc. | $98.96 | 6 | $0 (2018) |
| LivaNova USA, Inc. | $95.56 | 4 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $91.95 | 5 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $90.01 | 6 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $66.32 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $131.56 | 3 | Alexion Pharmaceuticals, Inc. ($86.91) |
| 2019 | $449.25 | 25 | Novartis Pharmaceuticals Corporation ($108.57) |
| 2018 | $746.80 | 45 | UCB, Inc. ($92.83) |
| 2017 | $815.84 | 55 | Novartis Pharmaceuticals Corporation ($112.76) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2020 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Neurological Disorders | ||||||
| 02/20/2020 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $86.91 | General |
| 01/06/2020 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $26.32 | General |
| Category: AED | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.18 | General |
| Category: AED | ||||||
| 08/30/2019 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2019 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2019 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Central Nervous System | ||||||
| 07/23/2019 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Neurology | ||||||
| 07/20/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $40.84 | General |
| 07/19/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $45.43 | General |
| Category: Immunology | ||||||
| 07/16/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2019 | Boston Scientific Corporation | VERCISE (Device) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: DBS | ||||||
| 05/01/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Neuroscience | ||||||
| 04/30/2019 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/29/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/16/2019 | GENZYME CORPORATION | AUBAGIO (Drug), LEMTRADA | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/20/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Central Nervous System | ||||||
| 03/20/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.09 | General |
| Category: Opioid Analgesic | ||||||
| 03/07/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Neuroscience | ||||||
| 02/26/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Immunology | ||||||
| 02/20/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 360 | 451 | $88,514 | $37,728 |
| 2022 | 8 | 409 | 487 | $128,097 | $42,647 |
| 2021 | 9 | 681 | 824 | $210,023 | $69,431 |
| 2020 | 7 | 323 | 388 | $89,447 | $32,028 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 116 | 118 | $29,211 | $11,731 | 40.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 104 | $21,160 | $9,453 | 44.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 122 | $15,264 | $7,381 | 48.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 52 | $17,464 | $6,666 | 38.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 39 | $2,839 | $1,483 | 52.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $2,576 | $1,015 | 39.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 123 | 124 | $40,344 | $12,772 | 31.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 88 | 135 | $29,991 | $10,525 | 35.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 39 | $16,782 | $5,719 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 39 | 39 | $12,715 | $4,049 | 31.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 72 | $12,094 | $3,882 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 44 | $9,590 | $3,487 | 36.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $3,697 | $1,359 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 16 | $2,884 | $853.61 | 29.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 238 | 242 | $85,624 | $25,203 | 29.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 134 | 205 | $42,453 | $16,391 | 38.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 151 | 204 | $33,698 | $11,387 | 33.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 44 | 44 | $14,300 | $4,985 | 34.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 41 | 52 | $10,631 | $4,291 | 40.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 26 | $13,920 | $4,067 | 29.2% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 12 | 12 | $4,092 | $1,346 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 23 | $4,025 | $1,284 | 31.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 16 | $1,280 | $476.63 | 37.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 76 | 76 | $23,351 | $8,173 | 35.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 60 | 87 | $17,874 | $7,057 | 39.5% |
About Dr. Ahmed Robbie, MD
Dr. Ahmed Robbie, MD is a Neurology healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801826052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ahmed Robbie, MD has received a total of $2,143 in payments from pharmaceutical and medical device companies, with $131.56 received in 2020. These payments were reported across 128 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,132).
As a Medicare-enrolled provider, Robbie has provided services to 1,773 Medicare beneficiaries, totaling 2,150 services with total Medicare billing of $181,834. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Joplin, MO
- Active Since 07/04/2006
- Last Updated 01/14/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1801826052
Products in Payments
- LYRICA (Drug) $150.99
- GILENYA (Drug) $144.17
- LEMTRADA (Drug) $120.06
- VNS Therapy (Device) $95.56
- AUBAGIO (Drug) $79.83
- AIMOVIG (Biological) $75.52
- Movantik (Drug) $70.34
- Vimpat (Drug) $67.46
- APTIOM (Drug) $64.59
- Briviact (Drug) $61.81
- Betaseron (Drug) $58.99
- TROKENDI XR (Drug) $54.45
- MAYZENT (Drug) $53.70
- AJOVY (Drug) $47.99
- TALTZ (Drug) $45.43
- Aimovig (Biological) $43.06
- NUPLAZID (Drug) $41.91
- OXTELLAR XR (Drug) $37.50
- Horizant (Drug) $37.08
- XTAMPZA (Drug) $32.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Joplin
Gulshan Uppal, M.d, M.D
Neurology — Payments: $173,810
Christopher Andrew, Md, MD
Neurology — Payments: $120,253
Rene Mosada, M.d, M.D
Neurology — Payments: $2,988
Dr. Arooj Kohli, Md, MD
Neurology — Payments: $299.97
Anna Wojcicka-Mitchell, M.d, M.D
Neurology — Payments: $238.29
Daniel Dagen, Do, DO
Neurology